Martyn Gibson, FCCA
Chief Financial Officer
As Symetria’s Chief Financial Officer, Martyn is responsible for all aspects of finance and accounting, IS infrastructure, strategic planning and forecasting, revenue and cash flow management.
Martyn joined Symetria following 12 years with Reckitt Benckiser Pharmaceuticals Inc. (now Indivior plc) supporting the commercialization and manufacture of Suboxone®, Subutex® and Buprenex®. Martyn served as Global Head of Finance for the division, with responsibilities including strategic planning, supply chain management and IS as part of the founding commercial leadership team.
Martyn has Fellowship designation from the Association of Chartered Certified Accountants (ACCA). Since 2008 has been an Honorary Board Member and Treasurer of a non-profit organization offering substance use disorder treatment services.
We take the time to develop a comprehensive picture of each patient’s:
- Personal history
- Medical history
- Home environment
- Recovery needs
- Personal strengths
This allows us to develop a comprehensive plan for an individualized road to recovery -- which the patient helps shape every step of the way. We believe that patients build confidence when they are invited to play active roles in their own care plans, and we encourage our patients to ask questions, share concerns, and provide input. This input helps patients, working together with their multidisciplinary personal care teams, shape a recovery plan that meets their individual goals.